In response to the recent E. coli outbreak linked to McDonald’s slivered onions, the fast-food giant has announced plans to invest over $100 million to aid in the recovery of affected franchisees and restore customer trust. Of this total, $65 million will be allocated to support franchise owners in the hardest-hit areas, helping mitigate the… Continue reading McDonald’s to invest more than $100 million to speed up recovery after E. coli outbreak

The return of President-elect Donald Trump to the White House, coupled with Republican control of Congress, is expected to bring substantial changes to U.S. health care policy, potentially affecting millions of Americans. Key areas of focus include the Affordable Care Act (ACA), Medicaid, drug pricing, and health insurance coverage options. These changes are likely to… Continue reading How Trump’s win could change your health care

Dr. Shirin Towfigh, a Beverly Hills-based surgeon with over 22 years of experience, is suing Medtronic, a global leader in medical devices, alleging that the company stole her patented design for a hernia mesh product specifically tailored for women. Towfigh discovered, through her work with hernia patients, that women experienced significantly more post-surgery complications than… Continue reading Beverly Hills surgeon sues Medtronic for patent infringement

AstraZeneca recently announced a major $2 billion investment in its U.S. operations, signaling an intensified commitment to its American market presence. This investment will enhance the company’s research and development (R&D) and expand its manufacturing infrastructure across the U.S., adding to its existing $1.5 billion U.S. capital allocation, totaling $3.5 billion by 2026. The initiative… Continue reading Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

The Food and Drug Administration (FDA) proposed on Thursday to end the use of oral phenylephrine, a common ingredient found in many over-the-counter cold and allergy medications, after concluding that it does not effectively relieve nasal congestion. This decision follows a comprehensive review of available data and comes over a year after FDA advisors unanimously… Continue reading FDA proposes ending use of decongestant found in many cold, allergy medicines

The recent election saw voters in seven out of ten states approving measures to protect abortion rights, but health policy experts express concern over the potential impacts of Donald Trump’s presidential victory on abortion access. Trump’s stance on abortion has fluctuated, currently favoring a state-level approach. However, his administration could restrict abortion federally, bypassing Congress… Continue reading How Trump’s victory could change abortion rights in America

Biogen on Wednesday reported third-quarter revenue and adjusted earnings that topped expectations while raising its full-year profit guidance, as sales of its breakthrough Alzheimer’s drug, Leqembi, and other new products gain traction.  Biogen now expects full-year adjusted earnings to come in between $16.10 and $16.60 per share, up from a previous forecast of $15.75 to $16.25… Continue reading Biogen tops estimates, raises profit guidance as Alzheimer’s drug Leqembi gains traction

Eli Lilly’s third-quarter earnings report fell short of Wall Street expectations, leading to a sharp drop in its stock price by over 12%. The company attributed the shortfall to underwhelming sales of its key weight-loss drug, Zepbound, and diabetes medication, Mounjaro, as well as a $2.8 billion charge related to its acquisition of Morphic Holding,… Continue reading Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance

Vancouver, British Columbia–(Newsfile Corp. – October 23, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a Health Canada-licensed manufacturer of psychedelic pharmaceuticals specializing in botanical psilocybin and MDMA, is proud to announce that the first group of patients with post-traumatic stress disorder (PTSD) in Australia has successfully received… Continue reading Optimi Health Announces First PTSD Patients Treated with MDMA Capsules in Australia

VANCOUVER, British Columbia, Oct. 23, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response (DDR) technologies announced today that it has received initial results from the proprietary Deep Docking AI platform. Rakovina employed the Deep Docking algorithm to evaluate billions of… Continue reading Rakovina Therapeutics Announces Initial Drug Candidates from Deep Docking AI Molecule Discovery Platform

HERZLIYA, Israel and CALGARY, Alberta, Oct. 21, 2024 (GLOBE NEWSWIRE) — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (“Innocan” or the “Company”), a pioneer in chronic pain management via Liposomal CBD drug products, today announced that it will be participating in The ThinkEquity Conference on October 30, 2024, at the Mandarin Oriental Hotel… Continue reading Innocan Pharma to Present at the 2024 ThinkEquity Conference

Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF)(“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, announces that Henry Du has joined Alpha Cognition as the VP of Finance and Accounting and interim Chief Financial Officer (CFO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241021373262/en/… Continue reading Alpha Cognition Announces Appointment of VP Finance and Accounting